Sam­sung's bi­o­log­ics plant in South Ko­rea re­ceives Form 483 over da­ta in­tegri­ty, oth­er ob­ser­va­tions

FDA in­spec­tors un­cov­ered da­ta in­tegri­ty con­cerns with Sam­sung’s bi­o­log­ics plant, ac­cord­ing to a Form 483 re­leased this week fol­low­ing a 10-day agency in­spec­tion of the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER